320P Phase 3 study of neoadjuvant pembrolizumab (Pembro) plus chemotherapy (Chemo) followed by adjuvant pembro for early-stage TNBC: KEYNOTE-522 magnetic resonance imaging (MRI) subgroup analysis | Publicación